A Phased Approach for preparation and organization of human biomonitoring studies. by Fiddicke, Ulrike et al.
International Journal of Hygiene and Environmental Health 232 (2021) 113684
Available online 26 December 2020
1438-4639/© 2021 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
A Phased Approach for preparation and organization of human 
biomonitoring studies 
Ulrike Fiddicke a,*, L. Kim Pack a, Hanna Tolonen b, Ovnair Sepai c, Marta Esteban López d, 
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A B S T R A C T   
Background: Human biomonitoring (HBM) studies like other epidemiological studies are costly and time- 
consuming. They require the administration of questionnaires and collection of biological samples, putting 
substantial burden on the participants which may result in low participation rates. The growing importance of 
HBM studies in epidemiology, exposure assessment and risk assessment underline the importance of optimizing 
study planning, designing and implementation thus minimizing the above-mentioned difficulties. 
Methods: Based on frameworks from survey design and fieldwork preparation of the European Joint Program 
HBM4EU, the German Environment Surveys and the COPHES/DEMOCOPHES twin projects combined with el-
ements of project management strategies, a Phased Approach has been developed, introducing a step-by-step 
guideline for the development of epidemiological studies. 
Results: The Phased Approach splits the process of developing a study into six phases: Phase 0 (Scoping and 
Planning): All aspects that are necessary to conduct a study are compiled and put on the agenda for decision- 
making. Phase 1 (Preparation and Testing): Instruments (e.g. questionnaires), materials (e.g. guidelines, infor-
mation), and ethics and data management issues, needing thorough preparation and testing before a study can 
start. Phase 2 (Initiation): Organization and acquisition of necessary equipment and engaging and training 
personnel. Phase 3 (Implementation): All procedures that require temporal proximity to the start date of field-
work, such as obtaining contact information of invitees. Phase 4 (Fieldwork and Analysis): Involvement of 
participants and chemical analysis of the collected samples. Phase 5 (Results and Evaluation): Final procedures 
leading to closure of the project, such as providing and communicating results. 
Conclusions: The separation of the planning and conduct of human biomonitoring studies into different phases 
creates the basis for a structured procedure and facilitates a step-by-step approach reducing costs, warranting 
high participation rates and increasing quality of conduct. Emphasis is put on a comprehensive scoping phase 
ensuring high quality of the study design, which is indispensable for reliable results.   
1. Introduction 
Early epidemiological studies often focused on infectious diseases 
and death; modern epidemiology has a broader application. Environ-
mental epidemiology studies can be classified into two categories: 
descriptive and analytical. Descriptive studies include case reports, 
ecological studies, and cluster studies while analytical studies are based 
on more detailed data from individuals that can be used to control for 
confounding, they are usually costlier and more labor-intensive. 
Human biomonitoring (HBM) studies are environmental epidemio-
logical studies and can be either descriptive or analytical in design. They 
include not only response to questionnaires, but also collection of bio-
logical samples such as urine or blood from the participants (Angerer 
et al., 2007). They aim at assessing the exposure levels of a population 
and establishing the exposure sources by applying statistical procedures 
on the laboratory results and the provided questionnaire responses 
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(Kolossa-Gehring et al., 2012; National Research Council, 2006). Some 
studies additionally include the collection of environmental samples 
such as tap water or indoor air or dust samples from the homes of the 
participants (Kolossa-Gehring et al., 2012). Collecting materials and 
data has to follow a structured and quality assured procedure because 
every single step of the study has an impact on the overall quality of the 
conclusions (Calafat and Needham, 2009; Heffernan et al., 2020). Each 
one of these single steps needs to be decided upon because it can 
enhance or deteriorate the survey results and it needs (restricted) re-
sources. Therefore, optimization of processes and resources is necessary. 
A so called “total survey design perspective” that considers all important 
aspects of study design can serve as orientation (Fowler, 2014). 
Epidemiological studies that include participants in fieldwork are 
costly. What makes HBM studies even more costly and complex is the 
need for collecting biological matrices, transport and conservation, the 
chemical analyses, and related issues e.g. control of contamination and 
ethical considerations. As HBM gains strength, for example in the field of 
risk assessment (Angerer et al., 2007; Bates et al., 2005; Choi et al., 
2015; Sobus et al., 2015) an increase in the numbers of HBM-studies is 
expected. At the same time, it has become more and more difficult to 
recruit volunteer participants for these time-consuming studies (Tolo-
nen, 2015; Blair and Czaja, 2014). 
HBM or other epidemiological studies require a wide variety of 
expertise such as project management, questionnaire development, data 
management, ethics, data protection, general and participant commu-
nication, logistics of materials and biological samples, chemical anal-
ysis, toxicology, statistics, personnel for the study conduct (interviewer, 
field staff, in some cases medical staff) etc. (Choi et al., 2014; Tolonen, 
2016). 
Successful conduct of a study relies on the development and execu-
tion of a well-organized research plan which includes the research 
question (incl. literature research), development of methods or in-
struments, study implementation as well as management and analysis of 
data and last but not least interaction and communication with partic-
ipants (Weber and Cobaugh, 2008). Support for organizing and man-
aging the resources for a defined project within a defined time period is 
provided by project management (Berkun, 2005). Project management 
includes establishing a multidisciplinary project team, defining, in bal-
ance with available financial resources, the project scope, developing a 
timeline, directing project activities, managing problems, and tracking 
the progress and ensuring quality in the whole process. For the devel-
opment of a timeline the study needs to be broken down into steps or 
clusters of tasks, to which resources have to be allocated (Weber and 
Cobaugh, 2008). Applying these principles of project management to the 
planning of a study can lead to a better organized and effective study 
(Weber and Cobaugh, 2008). 
Some support for the planning of epidemiological studies is provided 
by epidemiological associations when they explain which elements have 
to be generally considered or have to be described in a study protocol. 
According to the International Epidemiologic Association (IEA), “… the 
[study] protocol is the cornerstone of any epidemiological research project” 
(IEA 2007) which makes it the main instrument for implementing an 
epidemiological, or human biomonitoring, study. The study protocol - 
also called study plan, handbook, or book of operations – starts with a 
chapter about the purpose and the underlying hypotheses of the study. 
Following chapters refer to the study design, the study (target) popu-
lation and the sampling frame to be applied and details about planned 
activities and analyses. Furthermore, administrative issues, ethical and 
legal considerations and possible problems and limitations are described 
(IEA 2007). There are standards of good scientific practice for study 
conduct available and should be followed by all epidemiologic research 
initiatives (IEA, 2007). Such standards have been published e.g. by the 
American Chemical Manufacturers Association (Cook, 1991) and by the 
German Society for Epidemiology (DGEpi) (DGEpi, 2008; Hoffmann 
et al., 2019). Whenever a country or institution is striving to perform an 
epidemiological study, e.g. a health and/or nutrition survey or a human 
biomonitoring survey including collecting biospecimen, it is 
well-advised to respect these guidelines. 
However, while these standards provide useful guidelines, they do 
not inform about the roadmap for the planning of such studies which 
would be helpful considering the complexity of the studies and the 
different issues to be regarded. We propose here the Phased Approach 
which complements the existing literature on details of study design, 
fieldwork, ethics or data management (Ahrens and Pigeot, 2014) in 
providing a precise, practically and usefully structured, step-by-step 
approach for planning an epidemiological HBM-study in detail. 
2. Methods 
The Phased Approach was developed in the framework of the Eu-
ropean Joint Program HBM4EU (HBM4EU, 2020). It is based on expe-
riences of the German Environment Agency (UBA) which has conducted 
environmental surveys regularly since 1985 (Schulz et al., 2007). The 
experiences of the author and co-authors were already incorporated in 
the ESBIO project (Development of a coherent approach to human 
biomonitoring in Europe 2005–2007) (EU, 2013a) and the twin projects 
COPHES/DEMOCOPHES (EU 2013b; COPHES 2013), a European coor-
dination action on HBM, and now in the Horizon 2020 project HBM4EU 
(HBM4EU, 2020). 
In HBM4EU to some extent data from newly developed studies in 
different countries will be used. To facilitate data interpretation, this 
data should be collected using a standardized study protocol. In reality a 
‘one fits all’ study protocol does not exist. Even though the general 
design can be standardized to a significant extent each country still has 
to plan and coordinate an HBM-study on its own (Joas et al., 2012; 
Becker et al., 2014; Casteleyn et al., 2015). These facts were the reason 
to develop the Phased Approach. The Phased Approach was based on the 
aforementioned experiences and established through a profound liter-
ature research, including other fields of surveys, e.g. clinical trials, 
complemented with information from project management. It compiles 
all necessary steps for study conduct and puts them into the chrono-
logical order. 
For project management several commercially available project 
management tools exist but also the European Commission has devel-
oped an online available project management tool, called PM2, available 
for free. It is based on standards and methodologies of globally accepted 
project management best practices and also on experiences from several 
European Commission projects (European Commission, 2018). As the 
idea of the Phased Approach was developed in the frame of the European 
HBM4EU-Project the PM2 project management tool was selected to serve 
as a model for the Phased Approach. 
In the field of project management, it is common to operate projects 
in several – often five or six - phases to facilitate a proper follow-up of 
the different tasks involved. They start with an initiation or project 
conception phase, followed by a definition/planning phase and moving 
on to the development/project launching and execution phase also 
called implementation/performance phase. Finally, there is the follow- 
up or project closing phase (Baars, 2006). 
PM2 includes 4 project phases: 1) Initiating Phase; 2) Planning Phase; 
3) Executing Phase and 4) Closing Phase (European Commission, 2018: 
The PM2 Methodology Guide v3.0). The activities of monitoring and 
controlling are part of each of the four phases. A description of the 
content of the five phases is shown in Table 1. 
Besides the content of the single phases also their intertwining is of 
interest. 
Fig. 1 demonstrates that in each phase one activity is predominant (e. 
g. in the Initiating Phase activities of initiating are predominant) but 
that these phase-related activities will also be executed in neighboring 
phases, i.e. there is an overlap of activities or some activities are 
continued in other phases, e.g. initiating activities are repeated in the 
Planning Phase. A project moves on to the next phase when the goals of 
the current phase have been reached (ideally, results are reported 
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formally in a review). Although the Phased Approach intends to provide 
a step-by-step approach, an overlapping of some parts of a phase to the 
neighboring phases cannot completely be avoided and is partially 
necessary. 
For the Phased Approach six phases have been developed. This was 
necessary to strengthen the step-by-step approach which is really helpful 
not to get lost in the manifold topics an HBM study comprises. As 
pointed out by the IEA (IEA, 2007) the cornerstone of epidemiological 
projects is the ‘study protocol’, an instrument widely used for epide-
miological studies. It is a compilation and precise description of each 
issue necessary for the implementation, application, and evaluation of a 
study. Therefore, the Phased Approach is linked to the study protocol. 
Within this Phased Approach the key words of epidemiological studies 
(study design, selection of participants, recruitment, biological samples, 
fieldwork, questionnaires, analysis, interpretation and communication, 
and quality control) (Choi et al., 2014) are addressed as well. 
3. Results 
3.1. Overview of the Phased Approach 
The Phased Approach breaks down the process of mapping a study 
into the 6 phases of (0) scoping and planning (1), preparation and 
testing, (2) initiation, (3) implementation, (4) conducting the fieldwork 
and starting with analysis and (5) reporting and evaluation procedures 
to close the project. This way, a step-by-step procedure becomes 
apparent and facilitates the development of an individualized study 
concept and the implementation of the study. 
The numbering of the phases starts with “0” because there all general 
decisions necessary for the study conduct will be taken - this decision 
process is regularly not part of a study protocol where the Phased 
Approach is anchored. 
Fig. 2 presents a rough overview of the 6 phases which are explained 
in more detail in the following text. 
As an example, Fig. 3 provides an overview of a possible distribution 
of the workload (effort) for the six phases during a four-year period. In 
other studies, the duration of the phases will vary according to the 
survey design. 
3.2. Phase 0 – Scoping and Planning 
The Phase 0 sets the basis for all aspects of the study. Therefore, it is 
necessary to take the time for compiling all that is needed later on for the 
study and to prepare necessary decisions. 
Decisions that have to be taken refer to three main questions: 
Table 1 
Descriptions of the project phases in the PM2 project management tool.  
Phase Description of content 
1. Initiating 
Phase 
Define the desired outcomes. Create a Business Case. Define the 
project scope. Get the project off to a good start. 
2. Planning 
Phase 
Assign the Project Core Team (PCT). Elaborate the project scope. 
Plan the work. 
3. Executing 
Phase 
Coordinate the execution of project plans. Produce deliverables. 
4. Closing Phase Capture Lessons Learned and post-project recommendations. 
Close the project administratively. 
5. Monitor & 
Control 
Oversee all project work and management activities over the 
duration of the project: monitor project performance, measure 
progress, manage changes, address risks and issues, identify 
corrective actions etc.  
Fig. 1. The PM2 project lifecycle: indicative phase overlapping and cumulative 
effort (source: The PM2 Methodology Guide v3.0). 
Fig. 2. Overview of the 6 phases of the Phased Approach.  
Fig. 3. Example of a possible distribution of the workload (effort) for the six 
phases during a four-year period. 
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a) What? Scope and hypothesis of the study and planned research 
program, including the substances to be analyzed, and instruments, i. 
e. human and additional environmental samples, clinical examina-
tion and questionnaires (Table 2)  
b) Who? Target population and selected invitees (Table 3)  
c) How? Organization and organizational structure of the study, 
including the distribution of responsibilities and resources (Table 5). 
These questions need to be answered in detail, to disclose their in-
terconnections, and to facilitate a proper study conduct. 
This description of Phase 0 starts with a closer look first on the What? 
then on the Who? and finally on the How? questions. But the parts of the 
How? question dealing with responsibility and budget may be necessary 
to be decided in advance: who will take all these decisions, who will 
have to be included for taking specific decisions, which research pro-
gram is possible with the available budget? All these decisions belong to 
Phase 0, but without knowing what exactly the study consists of budget 
is difficult to estimate, therefore, in this text the What? questions 
precede the How? questions. 
3.2.1. Main question: What? 
An HBM study is usually conducted either to obtain the distribution 
of certain substances of interest in the population or to estimate the 
exposure level of a specific target population. For both questions the 
substance(s) of interest is a starting point for all further decisions, as 
target substances have implications on the study design, the question-
naires, and the fieldwork. For example, the substance impacts the matrix 
of the biological sample to collect and the half-life of the target chemical 
in the selected matrix impacts the time of sample collection which again 
has consequences for the fieldwork (collection procedures differ for 
different matrices). Also, statistical power calculations used to detect the 
necessary number of participants for a representative sample are based 
on the selected substances. More detailed aspects connected to the 
substances of interest are shown in Table 2. Another What? - also shown 
in Table 2 - concerns the questionnaires that regularly accompany HBM 
samples, e.g. to elucidate the exposure pathways of the target sub-
stances. When additional instruments, e.g. clinical examinations, or 
environmental samples are included in the study, additional issues in the 
“What?”-category have to be thought of. 
3.2.2. Main question: Who? 
The decision on what to study is closely connected to the question on 
target population (whom). Some countries may start their decision 
cascade with the decision on the target population and continue with the 
decisions on the substances, both decisions are closely related. 
Table 3 provides an overview of accompanying questions to the 
matter of the involved population. 
To be able to apply the results of the study to the target population, 
not only the sample of invitees needs to be representative for the target 
population but also those who actually participate (the participants) 
have to represent the target population which can only be achieved if the 
sample was representative for the target population. Decisions pertain-
ing the intended representativeness of the study have on the one hand a 
great influence on the way the fieldwork can be performed and on the 
other hand a high impact on data interpretation. Table 4 gives examples 
of how to obtain a representative sample in different population groups. 
A good sampling method for selection of individuals if no population 
registry for a random sample is available or applicable is e.g. the strat-
ified clustered multi-stage design. Via this design, geographical areas 
(stratification) are selected within a country. This can be applied if e.g. 
pregnant women shall be included and be approached when they arrive 
at the clinic before delivery. Within each of the geographical areas, 
primary sampling units (PSU), in this example the clinics (other exam-
ples: general practitioners, schools, work registries) are selected 
randomly, (or proportional to the number of individuals in these PSU). 
Furthermore, individuals are selected randomly within the PSU. 
Once the target population is defined, in order to assess if an invitee 
can be included in the study as a participant or not, the definition of 
eligibility criteria is necessary. As this may have influence on the 
necessary efforts to obtain the desired number of participants, the de-
cision on eligibility criteria is important at an early stage of planning of 
Table 2 
What? Things to consider and decide pertaining substances, questionnaires, and 
other additional instruments. Main question: Who?.  
Substances of interest Questionnaires (to 
elucidate exposure 
pathways and/or medical 
history) 
Clinical examinations (e. 
g. lung function tests, 
weight and height 
measurements) and 
additional environmental 
samples of the homes of 
the participants (e.g. 
indoor or outdoor air 
samples, tap water, dust)  
• Specified biomarkers 
(matrix/analyte): 
limits of quantification 
in the target 
population, time frame 
for sample collection  
• Analytical method: 
LOQ, certified 
reference material and 
standards, costs, etc.  













assurance aspects.  
• Processing of the 
samples during 
fieldwork (after 
receiving them from 
the participants)  
• Sample conservation 
and shipment  






of the samples  
• Qualified laboratories 
for the analyses 
(different labs may 
need different 
volumes)  




time activities, health 
history, medication, 
socio-economic back-
ground; for substances 
with short half-lives 
questions that cover 
the last 24–72 h past 







availability, history of 
contact); sampling 
questionnaires (i.e. 
period of sampling, 
recent exposure related 




questions and possible 










paper and pencil, web 
based) (also view 
“How?”)  





material, personnel)  
• necessary validation 
procedures for new 
instruments (e.g. new 
questionnaires or 
devices)  
• to whom shall which 
instrument be applied 
(to all participants or 
subgroups?)  
• time needed for the run 
of these procedures 
during fieldwork  
Table 3 
Who? Target population.  
Population aspects Decisions related to involved population 
Target population general population, risk-exposure groups 
(occupational, hot-spot) children, adults, etc. 
Definition of participants Age, sex, number; eligibility criteria 
Degree and direction of 
representativeness 
National, Regional, local, and according to sex and 
socio-economic status; oversampling of a subgroup 
Data to be collected (and 
stored?) 
Organizational aspects of data management; data 
protection 
Ethics committee for 
authorization 
Requirements of the selected ethics committee, 
procedure, and duration of the decision procedures  
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the study. The eligibility criteria should consider general aspects of the 
study design, e.g. the age of the participants, and others that can affect 
the results such as illness, language difficulties, hot spot areas or 
working in specific enterprises. 
A last but most important aspect pertaining the Who? is the 
compliance with ethical standards and data protection issues. The na-
tional and e.g. European regulations on ethical, legal and data protec-
tion issues have to be ascertained in an early state of the study planning 
to warrant proper compliance. 
3.2.3. Main question: How? 
Decisions on the How? already go deep into the details of a study. 
They involve the two aspects of 1) way of study conduct and general 
decisions necessary for this (based on the decision on the research 
program), and 2) organizational decisions (Table 5). 
The type of study has big implications on each aspect of the study 
conduct but also on the scientific significance especially if elucidating 
causality is aimed at. Cross-sectional studies, for example, can answer 
policy questions related to the actual exposure levels of the target 
population but cannot be used to answer questions on causality 
(Kleinbaum et al., 1982). Decisions on the sampling frame detail how 
invitees can be contacted. The timing (seasonal aspects) and duration of 
the fieldwork have implications on the representativeness and on 
organizational aspects of the study. The target groups and their 
respective occupation have to be reflected (e.g. a study planned to re-
cruit school children in schools should not start during holidays). Pref-
erably, a study should cover all four seasons to avoid seasonal variation 
of the outcome measures. If this is not possible, potential biases have to 
be taken into account. Time needed for training activities of the field 
staff before and during the fieldwork has to be considered appropriately. 
The decisions on the research program (What?) include decisions on 
the instruments to be applied, but it is also necessary to decide about 
the way how they shall be applied and how much time is needed, e.g. to 
answer the questionnaires. This duration has implications on the dura-
tion of the whole fieldwork. The more instruments shall be applied the 
more burden is put on the participants and this may also influence the 
participation rate (Mindell, 2015). Burden put on participants is an 
ethical aspect. Therefore, a balance between the necessities of the 
research program and the practical feasibilities of the study is necessary. 
Decisions on the place of direct contact to the participants, private 
homes, or centralized examination rooms, also have implications on the 
organization of the fieldwork. It is advisable to offer alternative possi-
bilities to comfort the participants, though it has to be checked if this is 
appropriate for the study instruments (home visits are necessary if e. g. 
indoor air or drinking water are to be collected by the field staff). 
In order to obtain high participation rates, it is advisable to identify 
potential obstacles in the enrolment process early on and think about 
ways how these could be addressed. Progress of the recruitment should 
also be monitored throughout the fieldwork and adapted if necessary. If 
ethics committee allows, additional incentives can be offered such as 
financial and in-kind compensations. Incentives can be provided un-
conditional or conditional to participation. Type and format of in-
centives should be addressed in the first information for the participants 
(invitation). 
Besides the quality control aspects pertaining the analytical and pre- 
analytical aspects of the samples and sample collection, quality control 
and quality assurance have to be applied for all instruments and the 
study as a whole. Internal quality control, e.g. for the fieldwork, can be 
performed by personnel of the unit of the institute or division not 
involved in the study. Additional external experts for quality control are 
especially advisable for larger research programs. Time for hiring and 
budget implications for these external experts have to be considered, 
too. 
To warrant high quality results, it is advisable to conduct a pilot 
study to prove the interaction and functionality of the main instruments 
with a small group of participants. Conducting a pilot study will include 
Table 4 
Methods for obtaining a representative sample in different population groups 
and their sampling frames.  
Target population Sampling frame (to 
select from the list of 
…) 
Methods for obtaining a 
representative sample 
General population of 
- adults 
- with or without 
children 
- or only children/ 
adolescents (separated 






a) Obtain a random sample, 
keep track of non-responders 
and dropouts 




Patient files of clinics/ 
doctors/midwives 
Obtain a random sample, 







a) Prepare a list of eligible 
sampling units (workplaces) 
for random sample 
b) Extract from large 
database/cohort 
Children/adolescents 
(different age groups) 
Kindergartens/day care 
centers, or their groups 
Prepare a list of eligible 
sampling units (schools, day 
care centers) for random 
sample 
Schools, vocational 
schools, or classes  
Table 5 
How? General decisions on way of study conduct, and on organizational struc-
ture, responsibilities, and budget.  
Study conduct, general decisions General decisions on organizational 
structure, personnel, and subcontracting  
• Study design (cross-sectional, cohort, 
etc.)  
• Organizational structure (Study 
Owner; Principal Investigator; Project 
Manager, managing team, etc.) 
•Sampling frame for the participants 
(how shall participants be contacted?)  
• Budgetary issues and allocation of 
financial, material, and human 
resources  
• Timing and duration of the fieldwork 
of the study (season (how many 
seasons?)  
• Personnel/responsibility for the 
preparation of all the written 
documents (like study protocol, 
Standard Operating Procedures 
(SOPs) for each instrument that is 
applied or developed, the data 
management and communication 
material for the participants, 
collaborating organizations and the 
general public  
• Repeated (?) involvement of 
individual participants in the study  
• Personnel/responsibility for 
organizational and pre-sampling pro-
cedures (e.g. mailing issues, prepara-
tion of sampling equipment/vessels)  
• Manner to apply selected instruments 
(e.g. questionnaires); collection and 
drop-off of biological samples; addi-
tional physical measurements  
• Personnel for execution of the 
fieldwork (nurses and/or professional 
interviewers), temporarily or 
permanent staff?  
• Place of study conduct/participant 
involvement (participant homes; place 
of productive hours like schools, 
workplace, or the official head quarter 
for the study (examination center like 
in schools, clinics, town halls) or 
mobile centers  
• Necessity for subcontracting (e.g. 
execution of fieldwork, laboratory 
work  
• Incentives for participants (if decided 
to provide, what kind? reimbursement 
for travel costs and/or for spending 
time and samples): Information on 
individual and general study results; 
small gifts and certificates for 
participation   
• Quality assurance of the whole 
program and single steps (internal, 
external?)   
• Pilot Study – which instruments and 
processes shall be tested?   
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additional time and budget as all decision steps for the main study have 
to be repeated (in parallel) for the pilot study. But the pilot study pro-
vides information on the feasibility of the actions and acceptability of 
measurements by participants and thus has implications to the costs and 
the quality of the results of the main study to a considerable extent 
(Becker et al., 2014; Biemer and Lyberg 2003). 
Additionally, and finally, decisions are also necessary on organiza-
tional issues, pertaining the structure and the personnel responsible for 
the main parts of the study (Table 5). 
To have a clear structure and a clarification of the sharing of re-
sponsibility is extremely important for the success of a complex study 
(Tolonen, 2016). According to project management, the establishment 
of a project team is a necessary activity to effectively plan and execute a 
project (Weber and Cobaugh, 2008). This supports the inclusion of 
different perspectives while setting up the research plan and planning 
the study. It plays an important role in ensuring the successful conduct of 
the project and for the concrete tasks, e.g. the preparation of all neces-
sary (written) material, but also for decisions in case of unforeseen 
events. Allocation of human resources is, like material and financial 
resources, included in budgetary decisions. Mostly the budget has a 
steering (often limiting) function on the structure, the number of par-
ticipants involved, the instruments applied, the duration and organiza-
tion of the fieldwork and the subcontracts or additional permanent or 
temporary staff required. 
The How? Questions also tackles the question on responsible 
personnel for developing the written material. Indispensable for the 
quality of an epidemiological study is the proper elaboration of written 
instructions, summarized in the study protocol and detailed in the 
Standard Operating Procedures (SOPs) and questionnaires. 
It will be necessary to develop diverse communication material, as 
communication is key to ensure a successful contact to the participants 
and to reach acceptable participation rates (Exley et al., 2015; Tolonen, 
2015). These might not only be written material but can also take the 
shape of information meetings for potential participants, informational 
videos, social media presence or websites. For this or, e.g. for a potential 
new corporate design for the study (a logo), subcontracts/tender pro-
cedures may have to be set up. 
Project management guidelines recommend preparing a timeline for 
the whole project. 
This could also be part of the Phase 0 or a first action of Phase 1. 
After these final decisions have been taken, Phase 0, the Scoping/ 
Planning Phase, ends. All theoretical considerations are now done. At 
this point the next phase starts with the elaboration of more details. 
3.3. Phase 1: Preparation and Testing 
The main focus of Phase 1 is on arranging those instruments and 
materials that need preparation and/or testing before they can be used 
for the study. If not already done in Phase 0, a first task of Phase 1 is the 
fixing of a timeline for the project. Also, it has to be safeguarded that the 
progress of each task is trackable (with indicators, milestones) to be able 
to steer the process. 
The first emphasis should then be put on the written materials 
because much of this is needed for the approval of the study by an 
ethics committee and the acceptance of the data protection officer. 
Both have to be approached in this phase and their approval carefully 
reviewed as it is a prerequisite for each study. Additionally, translations 
into different languages might be necessary which will also take some 
time. 
The preparation of a Fieldwork Manual, a collection of all written 
materials that are necessary for the fieldwork should start. 
The development of questionnaires is in itself a complex and time- 
consuming endeavor. Therefore, it is helpful to rely on already used and 
tested or validated questionnaires or questions whenever possible. A 
statistical analysis plan can help to streamline the questions to the 
research plan. Each question needs a justification or rationale for being 
asked and this background information should be put together in an 
Interviewer Manual if the questions are administered by interview. 
Otherwise this background information can be used for the elaboration 
of the information material for the participants (FAQs). Before questions 
or questionnaires can be applied to participants it is necessary to test 
them with at least 15 volunteers (Perneger recommends 30 (Pernegger, 
2015)) not only for the validation of the questions, but also to get an 
impression on the time needed for answering. This participant burden is 
of interest for ethic committees. If questionnaires are administered by 
computer assistance (CAPI/CATI/CASI/CAWI), respective codebooks 
for the programming of the questionnaires for computer programs have 
to be developed. 
Another part of the communication material that should be pre-
pared in this phase are all other information materials about the study 
itself (information leaflet, flyer etc.) and instructions for study partici-
pant, e.g. handling and storage of the samples the participants have to 
take themselves, such as the first morning urine samples. 
First ideas for the communication of the study to the target popula-
tion should also be developed in this phase. 
Suitable communication is key when aiming at ensuring a suc-
cessful contact to the participants and to reach acceptable participation 
rates. Therefore, already at this planning stage implications of the 
communication aspects are important to reflect (Exley et al., 2015; 
Fiddicke et al., 2015). 
Besides these written materials, other preparatory work should be 
started in this phase as shown in Table 6. 
3.4. Phase 2: Initiating 
Phase 2 comprises the concretization of the work ahead. All what is 
needed to be able to start with the fieldwork has to be turned into 
practice, initiated, e.g. material has to be bought or laboratories con-
tracted, and final decisions regarding fieldwork, laboratory work and 
data management have to be made and respective measures taken. At 
this point, all prerequisites for the study, like ethics authorization and 
data protection issues are already solved. 
Table 7 provides a detailed overview of the tasks of Phase 2. 
The Fieldwork Manual (and other written material) has to be 
checked for necessary updates (e.g. printing errors etc., but attention not 
to get into conflict with the already received ethical authorization) so it 
can be used for the training of the field staff. Training workshops pro-
vide an overview on the study itself, its background, the background of 
Table 6 
Preparatory work to be completed in Phase 1. After all this preparatory work is 
finalized, or at least well on track, the next, more detailed work can start in the 
Phase 2.  
Data management and incentives Laboratory work  
• Develop a data management plan  
• Creating a database for the contact 
details and the recruitment 
procedure  
• Creating a separate database for the 
questionnaire data and analytical 
results 
•If non-monetary incentives are plan-
ned their design should be prepared  
• For monetary incentives, a reception 
sheet should be prepared  
• According to QA/QC-criteria qualified 
laboratories for the selected biomarkers 
have to be contacted or a tender process 
be prepared.  
• Test the planned collection materials on 
their usability, e.g. tubes and vessels are 
free of contaminants, labels are suited 
for the sampling and storing conditions 
(temperature, humidity, etc.)  
• Prepare a sample reception protocol to 
be filled in by involved laboratories, 
necessary to control the integrity of the 
packaging and the conditions of the 
sample tubes and vessels (respect the 
General Data Protection Regulation)  
• Database of aliquots: Create a database 
including the sample ID code, aliquot ID 
code, sampling date, freezing date, type 
of sample, aliquots remaining after 
analysis, location in the bio bank, etc.  
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the questions and specific topics and explain the details of the workflow 
(how to plan and conduct the interview, how to take samples, sample 
aliquoting, transport, sample reception, filling out all documents 
involved in the sampling procedure etc.) The training should also pro-
vide hands on training, e.g. pertaining the samples and sampling and 
conducting interviews. 
Phase 2 also includes the creation of a detailed fieldwork schedule 
for the field staff with start date, end date and route plans concerning the 
involved study locations (towns, cities, or regions where the fieldwork 
will take place). 
The decisions pertaining the incentives or compensation, be it 
monetary or non-monetary, will need concretization in terms of buying 
(e.g. small gifts) or designing (certificate). 
The fieldwork logistics have to be planned and prepared including 
obtaining required devices and materials, their temporal storage, and 
transport to and from the fieldwork location. 
Laboratory equipment plays an important part in this phase. If the 
collected samples shall be (partly) processed directly in the field, it is 
necessary to ensure that minimum laboratory equipment will be avail-
able, e.g. refrigerator, centrifuge to warrant optimal conservation, and 
appropriate facilities to avoid the contamination of the samples. 
If transport of samples is foreseen, the packaging must fulfil the 
regulations (local and general) concerning the shipping of biological 
material. If the transport will be done by couriers, the details what exact 
their service covers needs to be checked in advance to prevent loss of 
samples. 
If external laboratories are involved (selected in Phase 1), contracts 
need to be negotiated, set up and signed. These contracts should also 
include the date of finalizing the analyses and the date and format for 
reporting the results. 
To further support the field staff or interviewers, a checklist with all 
materials and devices for a study visit can be compiled. 
All databases necessary and a data management plan have already 
been developed in Phase 1. Final test runs for these plans and databases 
can still be done in this Initiation Phase. 
3.5. Phase 3: Implementation 
Phase 3 deals with the ‘general’ recruitment. It pertains all that is 
needed to reach the target group that shall be involved in the planned 
study. It only begins some two-to-three weeks before the start of the 
fieldwork, which is defined as the direct involvement of the participants. 
What exactly is necessary in this phase varies according to the way 
volunteers will be included in the study. 
In general, for population based representative studies, an invitation 
to all persons of the selected sample of the sampling frame fitting to the 
target population is necessary. Often contact details are obtained from 
sampling frames, like population registries of selected towns or lists of 
pupils of selected schools. Another way is to contact selected schools to 
prepare teachers to be the promotor of the study in selected classes or to 
inform the parents via the school internet or special events that their 
children will be invited. Physicians, midwives, or selected maternities 
are sometimes approached to reach special groups of probable partici-
pants. The professionals need to agree and be prepared to forward in-
vitations to the persons that fit to the target group. Finally, as a result of 
this ‘general’ recruitment, one of the two options has to be accomplished 
either a list of potential participants to whom invitations can be sent 
shall be available or counterparts for direct participant contact are 
established – so the sample of the invitees is prepared. 
Timing of this ‘general’ recruitment is a sensible issue. It should not 
be done too long in advance before the fieldwork shall start because 
invitees might change addresses or approached counterparts are no 
longer available. This risk increases with the timely distance between 
searching for addresses and sending individual invitations. 
If addresses of individuals have been collected, they then can be 
transferred to the databases set up in Phase 2. Additionally, each indi-
vidual is assigned a study-specific ID number which serves for pseudo-
nymization of results. During this process and from here on out, data 
protection always has to be ensured. 
During this Implementation Phase also the visit at the first study 
location (i.e. the region or city where the study will take place) is pre-
pared. For example, the place or rooms that serve as examination centers 
have to be rented as well as rooms for field staff. Examination centers 
serve the needs for the study, i.e. consist of separate rooms (as waiting 
room or reception, room for interviews, room for exercises, sanitary 
facilities, etc.) and can be in schools, town halls, or clinics etc. They 
should be easily accessible and are necessary in each study location. If 
overnight stays of the fieldwork staff are necessary, this has also to be 
arranged. 
This is also a good period of time to raise awareness for the study and 
start communication with the target or additionally the general public 
about the study at the sampling location with the aim to increase the 
participation rate. 
Finally, the laboratories that will analyze the biological samples have 
to be informed about the upcoming start of the fieldwork so that they are 
ready to start with the first analysis. 
3.6. Phase 4: Fieldwork and Analysis 
Fieldwork starts with the direct contact to the individual partici-
pants. The first part of fieldwork (Fieldwork I) comprises the individual 
recruitment and starts directly after the general recruitment has pro-
vided the contact details of those who shall be invited or has informed 
about the way how to approach them. 
Invitations can now be sent, or direct contact be established. Invitees 
shall be provided different ways to articulate their acceptance or 
rejection of the invitation (e.g. personally, via phone, a reply card, 
email, or online tool). For organizational issues and to have the ability to 
calculate response rates it is necessary to keep track on the answers. 
Volunteers need to be contacted and checked for eligibility criteria. 
Those who will finally be included in the study, the participants, will be 
informed on their participation and probably sent detailed information 
or additional materials necessary for the study. Appointments for per-
sonal interviews or clinical examinations will be fixed. 
Individual recruitment can be very time consuming, as it is necessary 
to grant several days for response and provide several reminders – how 
many should be detailed in the Fieldwork Manual. 
In those cases where invitations have been sent but invitees did not 
react the field staff can still try to recruit them personally. For statistical 
reasons (representativeness) it is important to try very hard to reach 
each randomly selected participant (see Fieldwork II below). 
In case a potential participant refuses to participate, a non-responder 
Table 7 
Overview of the tasks of Phase 2.  
Remaining issues to get into the position to start the study  
• Updates of the Fieldwork Manual with all SOPs, communication material and 
questionnaires.  
• Engage qualified interviewers/fieldwork staff. 
•Organize and perform the training of the interviewers/fieldwork staff.  
• Decision on exact starting date and duration of the fieldwork, provide a route plan 
for the visit of included cities (sampling or study locations).  
• Organize/purchase the incentives which have been selected for the participants 
(books, bags, etc. with study logo) and a reception sheet for monetary incentives. 
•Purchase material for the sampling of the matrix to be collected (sample vessels, 
aliquot tubes) and material for the field staff (laboratory equipment, office, and 
dispatch material). If necessary, prepare the material for sampling (clean with acid 
solution, label it, etc.). Also, material for sample transport to the laboratory or biobank 
have to be considered.  
• Fix relation to targeted laboratories, sign contracts. Define the date and delivery 
format for the analytical results: type of file, units, report about the internal quality 
controls applied, etc.  
• Provide packing lists and prepared material for the field staff.  
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questionnaire should be administered to be able to compare non- 
participants with participants to check for potential response bias. 
During the whole fieldwork procedure – until the participants have 
received their individual results - a phone number and an email address 
of the general study office as contact address has to be provided. 
The second part of fieldwork (Fieldwork II) is the core element of 
the study. Here the participants are directly involved in the study: 
samples collected, questionnaires are applied, clinical examinations are 
carried out and afterwards incentives and results provided - all 
depending on the instruments decided upon in Phase 0 and precisely laid 
down in the Fieldwork Manual. 
An example for a schedule for the fieldwork procedures at study 
locations could be: Upon arrival at the study location the examination 
center is furnished with study equipment and devices. Before the visit of 
every single participant, the material (such as interviewer identity card, 
papers, laptop, additional sampling vessels, incentives etc.) is checked, 
prepared, and stocked up. On arrival of a single participant, the field 
staff checks and accepts the declaration of informed consent from the 
participant. Only then the other instruments of the study are applied, e. 
g. the questionnaire can be filled out, measurements and samples taken. 
In case not all parts of the fieldwork could be completed at once, an 
additional visit in the next few days should be offered to the participant. 
If the participant involvement takes place in the participants’ homes 
special care has to be taken. Respect for the residents and close obser-
vation of household etiquette is strongly recommended to avoid nega-
tive effects on participation rates. 
Each visit needs to be well documented with details concerning 
duration, completion, handovers and consent, and all procedures 
accompanied by quality control measures to warrant high quality of the 
received results. 
Procedures for handling of the samples collected from the partic-
ipants have been laid down in the Standard Operation Procedures (Phase 
1 and 2). Now, in this phase those SOPs have to be followed closely, e.g. 
aliquoting of the matrices, preparing for shipment or storage. 
If the study includes more than one study location all procedures will 
have to be repeated. 
In parallel, the laboratories can start analyzing samples to be 
prepared to report the results back to the participants (as laid down in 
the ethics documents). 
The managing site of the study (Principal Investigator, Survey Office) 
has to supervise the work of the field staff and to provide help and advice 
if necessary. Furthermore, internal quality control for fieldwork has to 
be established to check for signs of differential participation and to 
compare with the target population. It is further required to organize 
and conduct additional trainings for the field staff to maintain the 
quality of the fieldwork. 
Another important issue pertains the safeguarding of data protection. 
E. G. in Europe, the GDPR sets strict rules on the handling of sensitive 
personal data. Safeguarding compliance with the GDPR is a prerequisite 
for every study to be conducted in Europe. 
3.7. Phase 5: Reporting and Evaluation – Leading to Closure 
After the fieldwork is completed in one study location and the results 
of the sample analyses have been checked, the participants have a right 
(e.g. based on GDPR) to have their individual results reported back to 
them, preferably accompanied by some explanation if the values are 
prone to raise concern. After the fieldwork and the sample analyses are 
completed in all study locations results of the different instruments have 
to be merged and checked, participants who can count as a case have to 
be defined, i.e. who provided the information defined as indispensable 
(e.g. on smoking, alcohol/drugs use, diet, number of years living in the 
sampling location etc.). In the following, the cases are statistically 
analyzed according to the research questions. Only then advice for the 
(general) public and policies can be provided. 
Each part of the study should finally be evaluated – to support the 
conduct of following studies. 
This phase is to close the project – all remaining activities, like 
publishing results, reporting back to funding organizations and final-
izing contractual obligations are part of this last phase. 
The workload of the different parts involved in a study, like labo-
ratory work, ethics and data management activities, preparation and use 
of communication materials, questionnaire development and applica-
tion and fieldwork preparation and conduct are unequally distributed 
across the different phases. Fig. 4 provides an example for a schematic 
overview on the distribution of efforts of the different parts. 
4. Discussion 
Epidemiological studies consist of many elements and have high 
budgetary implications. These rise even more if it concerns a human 
biomonitoring study which includes not only the interview of volunteers 
but also biospecimen to be taken and analyzed. Given the wide range of 
biomarkers, biological matrices, analytical methods and influencing 
factors, the study design is a critical aspect in the efficient use of HBM in 
risk assessment (Choi et al., 2014). The planning of such a study should 
therefore be comprehensive and include all aspects such as research 
subjects, materials to be included, target population, selection of par-
ticipants, communication with all interested groups (stakeholders), 
biological analyses, data management, scientific publications, policy 
advice and first of all ethical and legal considerations. It is possible to 
find scientific publications on all of these single aspects and there are 
some guidelines available for good epidemiological practice. Also, 
several countries that run regular HBM programs have informed about 
their national strategy on human biomonitoring Belgium (Reynders 
et al., 2017; Schoeters et al., 2012), Canada (Haines et al., 2017), Czech 
Republic (Cerna et al., 2007, 2012), Denmark (Thomsen et al., 2008), 
France (Fréry et al., 2012), Germany (Kolossa-Gehring et al., 2012; 
Schulz et al., 2007). But none of these publications provide details on the 
complex procedure of planning a study or inform about an advisable 
Fig. 4. Example for a schematic overview on the distribution of efforts of the 
different parts involved in study conduct. 
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order for the planning of all the involved aspects. 
The Clinical Trials Transformation Initiative (CTTI, 2015) has 
developed quality-by-design principles for clinical trials to remove er-
rors with meaningful impact on the credibility of the results. They aim at 
promoting critical thinking about trial design to prospectively build 
quality into the scientific and operational design of clinical trials rather 
than relying on retrospective scientific reviews (Meeker-O’Connell et al., 
2016). These principles also include the study protocol design which 
contributes to high quality results if it is designed appropriately. 
A good example for the planning of studies is available for the Eu-
ropean Health Examination Survey (EHES). The EHES Manual (Tolonen, 
2016) provides guidelines for the implementation of standardized na-
tional health examination surveys (HES) in European countries but can 
also be a reliable source for studies in other fields. EHES proposes a 
circular planning procedure, consisting of 6 parts: (1) defining the scope 
of the study; (2) planning and preparation; (3) pre-testing and piloting; 
(4) final survey design, planning and preparing; (5) fieldwork and data 
collection; and (6) data file construction, analysis and reporting. Quality 
assurance aspects link these individual parts. After all is done, the 
planning for the next study can start in the same order. Tolonen also 
recommends links to project management tools (Tolonen, 2016). 
A similar attempt has been undertaken by Statistics Canada ‘Survey 
Methods and Practices’ providing insights into survey practices (Statis-
tics Canada 2003 and 2010). Like the EHES Manual (Tolonen, 2016) and 
the publication by Becker et al. (2014), all provide valuable information 
on alternative approaches for epidemiological studies, providing back-
ground information for an information-based decision making on nearly 
all aspects of study conduct. 
Further in-depth information on study-design is available, e.g. in 
Blair and Czaja 2014 and Flower 2014 (Blair and Czaja, 2014; Flower, 
2014). Both books elaborate on general and specific issues on survey 
design for research and provide a comprehensive overview of the 
sources of error and the range of methodological issues in survey data 
collection. The US National Research Council (National Research 
Council, 2006) describes in detail considerations in the design of bio-
monitoring studies and provides with this highly valuable information 
on several aspects of biomonitoring studies which could help the 
decision-making processes. 
Conducting a study involves many activities and several of them 
have to be started in parallel. None of the above-mentioned publications 
promote a structured concept or process for the planning of a study. To 
avoid not considering important aspects up front - and sometimes it 
might be too late to change things during the run of a study - the idea to 
develop a stringent concept for the planning of epidemiological/HBM 
studies arose and was turned into reality with the Phased Approach. 
As stated above, HBM studies need experts from different fields, i.e. 
multi- or interdisciplinary teams will work together. This in itself may 
pose some problems to the success of the project. To overcome such 
problems, Tobi and Kampen developed a Methodology for Interdisci-
plinary Research (MIR) framework (Tobi and Kampen, 2018) based on a 
process approach which puts the common goal of the researchers at the 
center of the project thus creating different phases of the process: first 
the research team discusses about the different parts of the design of 
their study and only then the study is executed. During the first dis-
cussion of the conceptual design of the study the ‘why’ (research 
objective) and ‘what’ (research question) of the research is decided. 
Then, the team discusses the technical design of the study (‘how’: study 
design; instrument selection or design; sampling plan; analysis plan). 
The execution of the work (including fieldwork) only starts after de-
cisions of the complete research design have been taken (Tobi and 
Kampen, 2018). This concept is closely related to the handbook of 
project management from Baars (2006), the definition phase is also 
addressed as “What?” and the Design phase with “How?”. The MIR 
framework and the Phased Approach have the technical part – 
answering the question of “How?” in common, it deals mainly with 
fieldwork. Whereas the “What?” describes the research question (MIR 
framework) and the research program (Phased Approach), respectively. 
This discrepancy can be explained with the fact that the Phased 
Approach does not include an extra phase for elucidating the research 
question as it was developed for studies conducted in the frame of 
HMB4EU where the research question is to a great extent already 
decided upon on the level of the HBM4EU project. MIR framework and 
Phased Approach do have in common that first decisions have to be 
taken (Phase 0) and only afterwards the execution of the study is pre-
pared and started. The Phased Approach was originally developed for 
(preferably population representative) HBM studies conducted in the 
frame of the European Joint Program HBM4EU though it can be adapted 
for other epidemiological studies. Conducting studies in the frame of 
HBM4EU has the consequence that the scope of and the research ques-
tion for the intended study has to be within the scope of HBM4EU, i.e. is 
restricted to certain substances and age groups. Additionally, the time 
frame for the study is set. In consequence the project conception phase, 
defining the scope and developing the research questions is no single 
phase in the Phased Approach but is included in the scoping/planning 
phase (Phase 0). This can be adapted if the Phased Approach is used in 
other contexts. 
5. Conclusion 
Complex (HBM) studies need considerable financial, material, and 
human resources. This obliges those responsible for the planning of a 
study to search for methods that support the ideal allocation of the 
available resources. A study can be dealt with like a project and there-
fore tools of project management can be applied. Project management, 
e.g. PM2 of the European Commission, separates the work within the 
project into several phases, like initiating, planning, executing, and 
closing phase which serves a structured procedure and a suitable allo-
cation of resources. Several years of experiences in planning different 
HBM studies lead to the introduction of project management tools into 
study design. This is done with the aim to support new researchers in the 
field of HBM studies in conceptualizing resource efficient studies. Re-
sources in terms of personnel and applied instruments can best be made 
use of if the concept of a study is thoroughly thought of. Therefore, the 
proposed Phased Approach lists all aspects which may occur in the later 
stages of a study already in the first phase as decision points. Only after 
all decisions are taken, the concrete work for the planned study shall 
start in a step-by-step approach. Following the Phased Approach can 
lead to a well-planned study resulting in highly valuable quality assured 
results with optimized allocation of resources. 
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